Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B

Published 12/02/2024, 17:30
Updated 12/02/2024, 18:40
© Reuters.  Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points on Monday.

The Dow traded up 0.48% to 38,856.99 while the NASDAQ rose 0.26% to 16,031.87. The S&P 500 also rose, gaining, 0.30% to 5,041.87.

Check This Out: Caterpillar, Marathon Petroleum And More On CNBC's 'Final Trades'

Leading and Lagging Sectors

Energy shares rose by 1.1% on Monday.

In trading on Monday, health care shares fell by 0.1%.

Top Headline

Gilead Sciences Inc (NASDAQ: GILD) agreed to acquire CymaBay Therapeutics Inc (NASDAQ: CBAY) for $32.50 per share in cash or a total equity value of $4.3 billion.

The addition of CymaBay’s investigational lead product candidate, seladelpar for primary biliary cholangitis (PBC) including pruritus, complements Gilead’s existing liver portfolio.

Equities Trading UP

Beamr Imaging Ltd. (NASDAQ: BMR) shares shot up 975% to $22.70 after the company announced it will present its joint research relating to automated video modernization with NVIDIA at the ACM Mile-High-Video 2024 conference.

Shares of ContextLogic Inc. (NASDAQ: WISH) got a boost, surging 46% to $6.59 after the company announced an agreement to sell substantially all of its operating assets and liabilities to Qoo10 for approximately $173 million in cash.

Millennium Group International Holdings Limited (NASDAQ: MGIH) shares were also up, gaining 500% to $6.18 after YC 1926 (BVI) Limited reported an 88.89% stake in the company in a 13G filing on Friday.

Equities Trading DOWN

AN2 Therapeutics, Inc. (NASDAQ: ANTX) shares dropped 75% to $5.04 after the company announced it will voluntarily pause enrollment in the Phase 3 part of the Phase 2/3 pivotal clinical trial evaluating epetraborole in treatment-refractory MAC lung disease.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Shares of WiSA Technologies, Inc. (NASDAQ: WISA) were down 37% to $0.05. WiSA Technologies priced 153,840,000 unit offering for gross proceeds of $10 million.

Big Lots, Inc. (NYSE: BIG) was down, falling 31% to $3.72 after the company reported preliminary fourth-quarter results.

Also Check This Out: Jim Cramer Says This Construction Giant Is 'So Good' And 'Goes Higher'

Commodities

In commodity news, oil traded down 0.2% to $76.69 while gold traded down 0.4% at $2,029.70.

Silver traded up 0.4% to $22.675 on Monday while copper rose 0.9% to $3.7150.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 rose 0.54%, London’s FTSE 100 rose 0.01% while Spain’s IBEX 35 Index rose 0.89% The German DAX rose 0.65% French CAC 40 rose 0.55% while Italy’s FTSE MIB Index gained 0.97%.

The BNP Paribas Real Estate Construction PMI in Ireland edged higher to 45.9 in January from December’s reading of 45.1.

Asia Pacific Markets

Asia Pacific markets closed lower on Monday, with India’s S&P BSE Sensex falling 0.60% and Australia’s S&P/ASX 200 falling 0.39%.

Economics

The U.S. Treasury statement for January will be released at 2:00 p.m. ET.

Now Read This: How To Earn $500 A Month From Coca-Cola Stock Ahead Of Q4 Print

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.